Keywords: The Medicines Company, GeNO, Equity stake, Nitric oxide platforms, Pulmonary hypertension, PAH

MedicinesCo takes equity stake in GeNO, gaining access to nitric oxide platforms

Article | 06 December 2011

USA-based The Medicines Company (Nasdaq: MDCO) says it has acquired a non-controlling equity investment in privately-held GeNO, an advanced, development-stage ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

GeNO

The Medicines Company

Go to company listing